Retatrutide 20mg

Retatrutide 20mg is a high-concentration, next-generation “triple agonist” peptide synthesized for advanced metabolic and endocrine research. Each vial contains 20mg of high-purity Retatrutide, designed to simultaneously target GLP-1, GIP, and Glucagon receptors. This research-grade compound is lyophilized to ensure maximum structural integrity and consistent results in academic and institutional studies.